Literature DB >> 17380369

The demise of Oregon's Medically Needy program: effects of losing prescription drug coverage.

Judy Zerzan1, Tina Edlund, Lisa Krois, Jeanene Smith.   

Abstract

BACKGROUND: In January 2003, people covered by Oregon's Medically Needy program lost benefits owing to state budget shortfalls. The Medically Needy program is a federally matched optional Medicaid program. In Oregon, this program mainly provided prescription drug benefits.
OBJECTIVE: To describe the Medically Needy population and determine how benefit loss affected this population's health and prescription use.
DESIGN: A 49-question telephone survey instrument created by the research team and administered by a research contractor. PARTICIPANTS: A random sample of 1,269 eligible enrollees in Oregon's Medically Needy Program. Response rate was 35% with 439 individuals, ages 21-91 and 64% women, completing the survey. MEASUREMENTS: Demographics, health information, and medication use at the time of the survey obtained from the interview. Medication use during the program obtained from administrative data.
RESULTS: In the 6 months after the Medically Needy program ended, 75% had skipped or stopped medications. Sixty percent of the respondents had cut back on their food budget, 47% had borrowed money, and 49% had skipped paying other bills to pay for medications. By self-report, there was no significant difference in emergency department visits, but a significant decrease in hospitalizations comparing 6 months before and after losing the program. Two-thirds of respondents rated their current health as poor or fair.
CONCLUSIONS: The Medically Needy program provided coverage for a low-income, chronically ill population. Since its termination, enrollees have decreased prescription drug use and increased financial burden. As states make program changes and Medicare Part D evolves, effects on vulnerable populations must be considered.

Entities:  

Mesh:

Year:  2007        PMID: 17380369      PMCID: PMC2219861          DOI: 10.1007/s11606-007-0178-4

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  28 in total

1.  Effect of a three-tier prescription copay on pharmaceutical and other medical utilization.

Authors:  B Motheral; K A Fairman
Journal:  Med Care       Date:  2001-12       Impact factor: 2.983

2.  Financial disparities in prescription drug use between elderly and nonelderly Americans.

Authors:  K Tom Xu
Journal:  Health Aff (Millwood)       Date:  2003 Sep-Oct       Impact factor: 6.301

3.  The dilemma of Medicaid.

Authors:  John K Iglehart
Journal:  N Engl J Med       Date:  2003-05-22       Impact factor: 91.245

4.  Problems paying out-of-pocket medication costs among older adults with diabetes.

Authors:  John D Piette; Michele Heisler; Todd H Wagner
Journal:  Diabetes Care       Date:  2004-02       Impact factor: 19.112

5.  Medication costs, adherence, and health outcomes among Medicare beneficiaries.

Authors:  Ramin Mojtabai; Mark Olfson
Journal:  Health Aff (Millwood)       Date:  2003 Jul-Aug       Impact factor: 6.301

6.  Adverse events associated with prescription drug cost-sharing among poor and elderly persons.

Authors:  R Tamblyn; R Laprise; J A Hanley; M Abrahamowicz; S Scott; N Mayo; J Hurley; R Grad; E Latimer; R Perreault; P McLeod; A Huang; P Larochelle; L Mallet
Journal:  JAMA       Date:  2001 Jan 24-31       Impact factor: 56.272

7.  Effect of generic-only drug benefits on seniors' medication use and financial burden.

Authors:  Chien-Wen Tseng; Robert H Brook; Emmett Keeler; W Neil Steers; Beth E Waitzfelder; Carol M Mangione
Journal:  Am J Manag Care       Date:  2006-09       Impact factor: 2.229

8.  Congruence of self-reported medications with pharmacy prescription records in low-income older adults.

Authors:  Grace I L Caskie; Sherry L Willis
Journal:  Gerontologist       Date:  2004-04

9.  Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.

Authors:  Chien-Wen Tseng; Robert H Brook; Emmett Keeler; Carol M Mangione
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

10.  A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women.

Authors:  Denise M Boudreau; Janet R Daling; Kathleen E Malone; Jacqueline S Gardner; David K Blough; Susan R Heckbert
Journal:  Am J Epidemiol       Date:  2004-02-01       Impact factor: 4.897

View more
  3 in total

Review 1.  What is the evidence for pharmaceutical patient assistance programs? A systematic review.

Authors:  Tisha M Felder; Nynikka R Palmer; Lincy S Lal; Patricia Dolan Mullen
Journal:  J Health Care Poor Underserved       Date:  2011-02

2.  Complex home care: Part 2- family annual income, insurance premium, and out-of-pocket expenses.

Authors:  Ubolrat Piamjariyakul; Donna Macan Yadrich; Vicki M Ross; Carol E Smith; Faye Clements; Arthur R Williams
Journal:  Nurs Econ       Date:  2010 Sep-Oct       Impact factor: 1.085

3.  States With Medically Needy Pathways: Differences in Long-Term and Temporary Medicaid Entry for Low-Income Medicare Beneficiaries.

Authors:  Laura M Keohane; Amal Trivedi; Vincent Mor
Journal:  Med Care Res Rev       Date:  2017-10-26       Impact factor: 3.929

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.